In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone
暂无分享,去创建一个
Simone Bersini | Matteo Moretti | Mara Gilardi | S. Bersini | M. Moretti | C. Arrigoni | M. Gilardi | Chiara Arrigoni
[1] D. Wilson. Tissue , 2009, The Lancet.
[2] M. Kerin,et al. Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells , 2009, International journal of cancer.
[3] Simone Bersini,et al. Human in vitro 3D co-culture model to engineer vascularized bone-mimicking tissues combining computational tools and statistical experimental approach. , 2016, Biomaterials.
[4] Mina J. Bissell,et al. The perivascular niche regulates breast tumor dormancy , 2013, Nature Cell Biology.
[5] Robert A. Weinberg,et al. Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.
[6] Wenshu Wu,et al. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis , 2011, Molecular Cancer.
[7] T. Guise,et al. Cancer-associated muscle weakness: What's bone got to do with it? , 2015, BoneKEy reports.
[8] Yu-Chi Chen,et al. Breast cancer metastasis to the bone: mechanisms of bone loss , 2010, Breast Cancer Research.
[9] Z. Bao,et al. Expression of MacMARCKS Restores Cell Adhesion to ICAM-1-Coated Surface , 2000, Cell adhesion and communication.
[10] I. Holen,et al. Human breast cancer bone metastasis in vitro and in vivo: a novel 3D model system for studies of tumour cell-bone cell interactions , 2015, Clinical & Experimental Metastasis.
[11] A. Magliocco,et al. Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment , 2012, Breast Cancer Research and Treatment.
[12] Matteo Moretti,et al. In vitro models of the metastatic cascade: from local invasion to extravasation. , 2014, Drug discovery today.
[13] J. Mitchison. Cell Biology , 1964, Nature.
[14] S. Bersini,et al. A 3D vascularized bone remodeling model combining osteoblasts and osteoclasts in a CaP nanoparticle-enriched matrix. , 2016, Nanomedicine.
[15] A. Fatatis,et al. Osteoblasts modulate Ca2+ signaling in bone-metastatic prostate and breast cancer cells , 2009, Clinical & Experimental Metastasis.
[16] Arnaud Scherberich,et al. Transcriptional regulation of tenascin‐W by TGF‐beta signaling in the bone metastatic niche of breast cancer cells , 2015, International journal of cancer.
[17] Yasuhiro Kobayashi,et al. Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals. , 2011, Frontiers in bioscience.
[18] N. Kosaka,et al. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells , 2014, Science Signaling.
[19] A. Ridley,et al. Crossing the endothelial barrier during metastasis , 2013, Nature Reviews Cancer.
[20] R. Hynes,et al. Platelets guide the formation of early metastatic niches , 2014, Proceedings of the National Academy of Sciences.
[21] A. Axel,et al. Interleukin‐6 is a potent growth factor for ER‐α‐positive human breast cancer , 2007 .
[22] Peter C. Searson,et al. In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform , 2016, Front. Bioeng. Biotechnol..
[23] R. Girgert,et al. Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells. , 2015, International journal of oncology.
[24] K Yano,et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[25] Yan Sun,et al. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway. , 2015, Cancer research.
[26] M. Junttila,et al. Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.
[27] A. Tutt,et al. A novel model of dormancy for bone metastatic breast cancer cells. , 2013, Cancer research.
[28] M. Smyth,et al. The pre-metastatic niche: finding common ground , 2013, Cancer and Metastasis Reviews.
[29] J. Gong,et al. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer , 2011, Molecular and Cellular Biochemistry.
[30] J. Canon,et al. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model , 2012, Breast Cancer Research and Treatment.
[31] A. Sullivan,et al. Comparative survival in tissue culture of normal and neoplastic human cells exposed to adriamycin. , 1974, Cancer research.
[32] R. Weinberg,et al. Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. , 2016, Cancer discovery.
[33] C. Rochlitz,et al. Global Gene Expression Analysis of the Interaction between Cancer Cells and Osteoblasts to Predict Bone Metastasis in Breast Cancer , 2012, PloS one.
[34] Christopher S. Chen,et al. Deconstructing Dimensionality , 2013, Science.
[35] Abhay Pandit,et al. Recreating complex pathophysiologies in vitro with extracellular matrix surrogates for anticancer therapeutics screening. , 2016, Drug discovery today.
[36] F. Jakob,et al. Breast carcinoma cells modulate the chemoattractive activity of human bone marrow‐derived mesenchymal stromal cells by interfering with CXCL12 , 2015, International journal of cancer.
[37] G. Baldini,et al. Breast adenocarcinoma MCF-7 cell line induces spontaneous osteoclastogenesis via a RANK-ligand-dependent pathway. , 2008, Acta histochemica.
[38] S. Stock,et al. Regulation of Breast Cancer-induced Bone Lesions by β-Catenin Protein Signaling* , 2011, The Journal of Biological Chemistry.
[39] T. Nagasawa. CXCL12/SDF-1 and CXCR4 , 2015, Front. Immunol..
[40] K. Horas,et al. Animal Models for Breast Cancer Metastasis to Bone: Opportunities and Limitations , 2015, Cancer investigation.
[41] D. Amadori,et al. CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems. , 2014, Bone.
[42] L. Beex,et al. Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis , 1991, Breast Cancer Research and Treatment.
[43] T. Oskarsson,et al. Extracellular matrix players in metastatic niches , 2012, The EMBO journal.
[44] C. Contag,et al. Animal models of bone metastasis , 2003, Cancer.
[45] R. Weinberg,et al. A Perspective on Cancer Cell Metastasis , 2011, Science.
[46] H. Putter,et al. Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials , 2015, European journal of cancer.
[47] V. Fowler,et al. Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. , 2005, Bone.
[48] E. Vogler,et al. In Vitro Mimics of Bone Remodeling and the Vicious Cycle of Cancer in Bone , 2014, Journal of cellular physiology.
[49] Yibin Kang,et al. IMPLICATIONS FOR OSTEOLYTIC BONE METASTASES * , 2007, Journal of Biological Chemistry.
[50] C. Polychronakos,et al. The kisspeptin (KiSS-1)/GPR54 system in cancer biology. , 2008, Cancer treatment reviews.
[51] A. Mastro,et al. Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment , 2015, Clinical & Experimental Metastasis.
[52] Steven J. Greco,et al. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. , 2011, Cancer research.
[53] J. Wesseling,et al. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. , 1996, Molecular biology of the cell.
[54] A. Scherberich,et al. Murine tenascin-W: a novel mammalian tenascin expressed in kidney and at sites of bone and smooth muscle development , 2004, Journal of Cell Science.
[55] L. Suva,et al. Osteoprotegrin and the bone homing and colonization potential of breast cancer cells , 2008, Journal of cellular biochemistry.
[56] E. C. Weir,et al. A Role for Cell-Surface CSF-1 in Osteoblast-mediated Osteoclastogenesis , 2002, Calcified Tissue International.
[57] B. Paradiso,et al. The stimulation of A(3) adenosine receptors reduces bone-residing breast cancer in a rat preclinical model. , 2013, European journal of cancer.
[58] K. Pienta,et al. Cancer cells homing to bone: the significance of chemotaxis and cell adhesion. , 2004, Cancer treatment and research.
[59] K. Packman,et al. Mesenchymal Stem Cells in Early Entry of Breast Cancer into Bone Marrow , 2008, PloS one.
[60] G. Emons,et al. Kisspeptin-10 inhibits bone-directed migration of GPR54-positive breast cancer cells: Evidence for a dose-window effect. , 2010, Gynecologic oncology.
[61] M. Suzui,et al. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer. , 2016, Advanced drug delivery reviews.
[62] R. Parshad,et al. Search for "indicators" of neoplastic conversion in vitro. , 1967, Journal of the National Cancer Institute.
[63] Y. Harazono,et al. Galectin-3 Inhibits Osteoblast Differentiation through Notch Signaling12 , 2014, Neoplasia.
[64] P. Mehdipour,et al. Genetics of breast cancer bone metastasis: a sequential multistep pattern , 2014, Clinical & Experimental Metastasis.
[65] J. Chirgwin,et al. Molecular biology of bone metastasis. , 2008, Molecular cancer therapeutics.
[66] K. Hess,et al. Estrogen Receptors and Distinct Patterns of Breast Cancer Relapse , 2003, Breast Cancer Research and Treatment.
[67] R. Kappelhoff,et al. Microarray and Proteomic Analysis of Breast Cancer Cell and Osteoblast Co-cultures , 2011, The Journal of Biological Chemistry.
[68] Eithne Costello,et al. From mice to men: Murine models of colorectal cancer for use in translational research. , 2016, Critical reviews in oncology/hematology.
[69] P. Hauschka,et al. Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis. , 2010, The American journal of pathology.
[70] Michael T Lewis,et al. Patient-derived xenograft models of breast cancer and their predictive power , 2015, Breast Cancer Research.
[71] R. Coleman. Skeletal complications of malignancy , 1997, Cancer.
[72] D. Lacey,et al. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors , 1999, Journal of cellular biochemistry.
[73] G. Dubini,et al. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation , 2014, Proceedings of the National Academy of Sciences.
[74] Stephen T. C. Wong,et al. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. , 2015, Cancer cell.
[75] P. De Luca,et al. Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL / OPG ratio in human breast cancer cells generating bone metastases , 2014 .
[76] Z. Yao,et al. Effect of truncated neurokinin‐1 receptor expression changes on the interaction between human breast cancer and bone marrow‐derived mesenchymal stem cells , 2014, Genes to cells : devoted to molecular & cellular mechanisms.
[77] Anna V. Taubenberger,et al. In vitro microenvironments to study breast cancer bone colonisation. , 2014, Advanced drug delivery reviews.
[78] G. Dubini,et al. A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. , 2014, Biomaterials.
[79] J. Massagué,et al. Metastatic colonization by circulating tumour cells , 2016, Nature.
[80] Chiang-Ching Huang,et al. Identification of estrogen-responsive genes involved in breast cancer metastases to the bone , 2007, Clinical & Experimental Metastasis.
[81] T. Kipps,et al. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.
[82] N. Morrison,et al. MCP-1 Is Induced by Receptor Activator of Nuclear Factor-κB Ligand, Promotes Human Osteoclast Fusion, and Rescues Granulocyte Macrophage Colony-stimulating Factor Suppression of Osteoclast Formation* , 2005, Journal of Biological Chemistry.
[83] Jian Lu,et al. Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis , 2016, Nature Communications.
[84] H. Qin,et al. Calcitonin Gene-Related Peptide Inhibits Osteolytic Factors Induced by Osteoblast In Co-Culture System with Breast Cancer , 2014, Cell Biochemistry and Biophysics.
[85] D. Venzon,et al. Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer , 2010, Journal of cellular biochemistry.
[86] R. Sutherland,et al. Direct Crosstalk Between Cancer and Osteoblast Lineage Cells Fuels Metastatic Growth in Bone via Auto‐Amplification of IL‐6 and RANKL Signaling Pathways , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.